![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Dragon Announces Financial Results for the First Quarter of 2005
Dragon Announces Financial Results for the First Quarter of 2005
May 18, 2005
Dragon Pharmaceutical has announced the financial results for the first quarter of 2005. Revenues increased 65 percent for the first quarter of 2005 compared to the same period of the prior year reaching US$11.24 million. Chemical division revenues for the first quarter of 2005 increased over 5.5 times compared to the same period of the prior year reaching $5.70 million, surpassing the divisional revenues for the full year of 2004 ($4.25 million). Net profit reached $1.24 million or $0.02 per share. $8.45 million bank loan due in April 2005 has been renegotiated, of which $6.64 million has been renewed for two years and $1.81 million has been renewed for one year.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct